Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials